Resolutions of Eevia Health Plc's Extraordinary General Meeting on December 9, 2021
An Extraordinary General Meeting ("EGM") of shareholders of Eevia Health Plc was held in Seinäjoki, on December 9, 2021. Three shareholders representing 2,882,200 shares and votes (20,6 % of total shares) were represented at the meeting. The EGM unanimously decided on the proposal from the Board of Directors as described in the Notice of Extraordinary General Meeting.
The Extraordinary General Meeting resolved on the following issue:
Authorizing the Board of Directors to decide on issuance of shares
The EGM resolved in accordance with the proposal from the Board of Directors to authorize the Board of Directors to decide, in one or more transactions, on the issuance of shares against payment as follows: The number of shares to be issued based on the authorization may in total amount to a maximum of 2,061,856 shares. The Board of Directors decides on all other terms and conditions of the issuances of shares. The issuance of shares may be carried out in deviation from the shareholders' pre-emptive rights (directed issue), if there is a weighty financial reason for the company. The authorization is valid until May 31st, 2022.
Resolution on directed share issue by the Board of Directors
The Board of Directors of Eevia Health Plc has resolved, based on the authorization received from the Extraordinary General Meeting, on a directed new issue of 2,061,856 shares at a subscription price of SEK 9.70 per share (the "Directed Share Issue"), which is expected to raise proceeds to the Company of SEK 20 million before issue costs. The purpose of the Directed Share Issue is to increase and broaden the shareholder base with qualified and long-term investors and also in a cost-effective and timely manner raise capital to improve the Company's financial position and to enable the further development and growth of the Company's business. The Board is of the opinion that the Directed Share Issue will be of benefit to the Company and, therefore, to all its shareholders.
Other information related to the Directed Share Issue has been published on 11 November 2021 in a press release.